We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-3.84%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$6.16B
AUM Growth
+$1.7B
Cap. Flow
+$2.17B
Cap. Flow %
35.15%
Top 10 Hldgs %
26.62%
Holding
7,028
New
630
Increased
3,221
Reduced
2,151
Closed
574

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$204M
2
MSFT icon
Microsoft
MSFT
+$195M
3
AMZN icon
Amazon
AMZN
+$97.4M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$95M
5
TSM icon
TSMC
TSM
+$69.5M

Sector Composition

Rank Sector Weight
1 Technology 27%
2 Healthcare 10.88%
3 Consumer Discretionary 10.71%
4 Financials 8.69%
5 Communication Services 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEWT icon
3026
NewtekOne
NEWT
$376M
$58K ﹤0.01%
3,541
-904
-20% -$18.5K
PANL icon
3027
Pangaea Logistics
PANL
$495M
$58K ﹤0.01%
12,496
+728
+6% +$3.57K
PBR.A icon
3028
Petrobras Class A
PBR.A
$104B
$58K ﹤0.01%
5,298
-7,467
-58% -$89.8K
TDS icon
3029
Telephone and Data Systems
TDS
$4.06B
$58K ﹤0.01%
4,131
+223
+6% +$3.54K
WTBA icon
3030
West Bancorporation
WTBA
$512M
$58K ﹤0.01%
2,793
+2,003
+254% +$48.3K
PCSB
3031
DELISTED
PCSB Financial Corporation
PCSB
$58K ﹤0.01%
3,252
-7,890
-71% -$150K
ADMA icon
3032
ADMA Biologics
ADMA
$2.1B
$57K ﹤0.01%
23,397
-12,636
-35% -$30.3K
JBIO
3033
Jade Biosciences
JBIO
$1.52B
$57K ﹤0.01%
99
+84
+560% +$56.1K
DGII icon
3034
Digi International
DGII
$3.23B
$57K ﹤0.01%
1,648
+470
+40% +$14.6K
EBS icon
3035
Emergent Biosolutions
EBS
$230M
$57K ﹤0.01%
2,700
-9,248
-77% -$257K
FMAO icon
3036
Farmers & Merchants Bancorp
FMAO
$487M
$57K ﹤0.01%
2,135
+1,000
+88% +$29.8K
FUBO icon
3037
FuboTV Inc
FUBO
$301M
$57K ﹤0.01%
1,342
-705
-34% -$30.3K
HCAT icon
3038
Health Catalyst
HCAT
$134M
$57K ﹤0.01%
5,840
-15,892
-73% -$210K
INSE icon
3039
Inspired Entertainment
INSE
$169M
$57K ﹤0.01%
6,365
-8,211
-56% -$84.7K
IVV icon
3040
iShares Core S&P 500 ETF
IVV
$911B
$57K ﹤0.01%
158
-23,605
-99% -$9.43M
KRON
3041
DELISTED
Kronos Bio
KRON
$57K ﹤0.01%
16,964
+13,656
+413% +$61.6K
MVBF icon
3042
MVB Financial
MVBF
$401M
$57K ﹤0.01%
2,039
+1,122
+122% +$36.1K
NBR icon
3043
Nabors Industries
NBR
$1.39B
$57K ﹤0.01%
565
+267
+90% +$32.7K
NVCR icon
3044
NovoCure
NVCR
$1.97B
$57K ﹤0.01%
738
-2,089
-74% -$163K
OPY icon
3045
Oppenheimer Holdings
OPY
$1.24B
$57K ﹤0.01%
1,830
+1,489
+437% +$52.1K
PGEN icon
3046
Precigen
PGEN
$2.26B
$57K ﹤0.01%
27,090
+1,262
+5% +$2.66K
PRG icon
3047
PROG Holdings
PRG
$1.71B
$57K ﹤0.01%
3,836
+1,740
+83% +$32.7K
RXT icon
3048
Rackspace Technology
RXT
$1.07B
$57K ﹤0.01%
14,072
+3,215
+30% +$18.7K
TDUP icon
3049
ThredUp
TDUP
$414M
$57K ﹤0.01%
31,265
+2,193
+8% +$5.5K
TX icon
3050
Ternium
TX
$10.7B
$57K ﹤0.01%
+2,096
New +$67.4K

Similar funds

Tower Research Capital (TRC)'s Q3 2022 Portfolio in Review

As of Q3 2022, Tower Research Capital (TRC) held 7,028 positions worth $6.16B, up 38% from $4.46B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $2.17B of net new capital in Q3 2022, opening 630 new positions and adding to 3,221 existing holdings. Its largest new stake was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $53M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2022 buy was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.
  • Tower Research Capital (TRC) added most to Apple in Q3 2022, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $53M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Portfolio S&P 500 ETF in Q3 2022, selling an estimated $6.39M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $6.16B portfolio in Q3 2022.
  • Tower Research Capital (TRC) opened 630 new positions and closed 574 in Q3 2022.
  • Tower Research Capital (TRC)'s portfolio value rose 38% quarter-over-quarter to $6.16B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2022, filed 10 Nov 2022.